India Globalization Capital
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial...
India Globalization Capital Logo
About India Globalization Capital
IGC Pharma, Inc. operates as a biopharmaceutical company. The Company develops cannabinoid-based formulations for treating diseases and conditions including but not limited to Alzheimer's disease, period cramps, premenstrual syndrome (PMS), and chronic pain. IGC Pharma serves the healthcare sector in the United States.
Address
10224 Falls Road,
Potomac, 20854
United States
Year founded
2005
Number of employees
67
